login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
HEART TEST LABORATORIES-CW27 (HSCSW) Stock News
NASDAQ:HSCSW -
0.06
USD
0 (0%)
Last: 8/26/2025, 10:52:46 AM
Overview
Stock Chart
Technical Analysis
News
HSCSW Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: HeartSciences Inc.
- Mentions:
HSCS
HeartSciences Announces Conference Participation and Investor Webinar
11 days ago - By: HeartSciences Inc.
- Mentions:
HSCS
HeartSciences Announces Conference Participation and Investor Webinar
a month ago - By: HeartSciences Inc.
- Mentions:
HSCS
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
a month ago - By: HeartSciences Inc.
- Mentions:
HSCS
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
3 months ago - By: Yahoo Finance
- Mentions:
RNXT
BBY
HSCS
KSCP
...
RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results
3 months ago - By: HeartSciences Inc.
- Mentions:
HSCS
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
3 months ago - By: HeartSciences Inc.
- Mentions:
HSCS
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
3 months ago - By: HeartSciences Inc.
- Mentions:
HSCS
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
3 months ago - By: HeartSciences Inc.
- Mentions:
HSCS
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
3 months ago - By: HeartSciences Inc.
- Mentions:
HSCS
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
3 months ago - By: HeartSciences Inc.
- Mentions:
HSCS
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
3 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025
3 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025
4 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
4 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
4 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
4 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
4 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
4 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
6 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results
6 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results
6 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications
6 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications
8 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results
8 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results
10 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement
10 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement
11 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit
11 months ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit
a year ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results
a year ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results
a year ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission
a year ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission
a year ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results
a year ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results
a year ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency
a year ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency
a year ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
a year ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
a year ago - By: Heart Test Laboratories, Inc.
- Mentions:
HSCS
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
Please enable JavaScript to continue using this application.